Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001053754 | SCV001218031 | uncertain significance | Axenfeld-Rieger syndrome type 1; Anterior segment dysgenesis 4 | 2019-04-16 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C45"). This variant has not been reported in the literature in individuals with PITX2-related conditions. This variant is present in population databases (rs571758306, ExAC 0.009%). This sequence change replaces serine with asparagine at codon 261 of the PITX2 protein (p.Ser261Asn). The serine residue is highly conserved and there is a small physicochemical difference between serine and asparagine. |
Ambry Genetics | RCV002553328 | SCV003742177 | uncertain significance | Inborn genetic diseases | 2021-08-19 | criteria provided, single submitter | clinical testing | The c.782G>A (p.S261N) alteration is located in exon 5 (coding exon 3) of the PITX2 gene. This alteration results from a G to A substitution at nucleotide position 782, causing the serine (S) at amino acid position 261 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |